Biodexa Pharmaceuticals PLC, an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today ...
RAMAT GAN, ISRAEL, March 20, 2026 (GLOBE NEWSWIRE)-- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it plans to change the ratio of its ...
111, Inc. announced that it plans to change the ratio of its American Depositary Shares to Class A ordinary shares from one ADS representing two Class A ordinary shares to the new ratio of one ADS ...
BEIJING, Aug. 20, 2025 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo" or the "Company"), a leading gig economy platform focusing on local life services, today announced that it will change the ...
BURLINGTON, Mass. and JERUSALEM, Feb. 17, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results